This web only provides the extract of this article. If you want to read the figures and tables, please reference the PDF full text on Blackwell Synergy. Thank you.
- .Letters to the Editor -
Endotoxins in the prostatic secretions of chronic prostatitis patients: a need for further biomarkers through the use of proteomics
Sashi S. Kommu1, Stewart Reiss2
1The Royal Marsden NHS Foundation Trust, Fulham Road, London SW3 6JJ, UK
2Brighton and Sussex Medical School, University of Sussex, Brighton, BN1 9PX, UK
Abstract
Keywords:
Correspondence to: Dr Sashi S. Kommu, The Royal Marsden NHS Foundation Trust,Fulham Road, London SW3 6JJ, UK
Tel: +020-8337-6691, Fax: +020-8335-3325; E-mail: sashurol@gmail.com; sashi.kommu@icr.ac.uk
Received 2005-04-07 Accepted 2005-05-26
DOI: 10.1111/j.1745-7262.2006.00098.x
Dear Sir,
Dai et al.[1] must be commended on their useful
investigation of the clinical significance of endotoxins in
the expressed prostatic secretions (EPS) of chronic
prostatitis (CP) patients. However, we take issue with their
conclusion. The conclusion that EPS endotoxin
determination is helpful in diagnostic confirmation is plausible,
however, the conclusion that it is also useful in
evaluating the response to treatment in CP patients is not
supported by the findings of their study. CP may express
endotoxin, but unless we can demonstrate that there is a
near linear reduction in endotoxin levels, following
treatment of patients, one cannot make the conclusion that it
will be helpful in evaluating response to treatment. This
is complicated by the recent doubts raised about
classification systems of CP by several groups, including Nickel
et al. [2].
We wish to add a few thoughts as to the implications
and potential for expanding on the results of this study.
The findings prompt us to explore the role of multiple or
supplementary markers [3] as a panel to arrive at a
cumulative scoring system. In a study by Ludwig
et al. [4] it was concluded that the determination of leukocytes in urine
after prostatic massage is a feasible and reliable method
compared with the analysis of EPS. Immunocytological
analysis [5] of leukocyte subpopulations in urine
specimens before and after prostatic massage showed that
granulocytes are the predominant cell type of inflammation, but
other leukocytes included macrophages and T and B lymphocytes. This indicated that both the cellular and
humoral immune systems might be involved in the inflammatory process.
When using the "four glass test", that is, first-void
urine (VB1), midstream urine (VB2), expressed prostatic
secretions (EPS), and post massage urine (VB3), Krieger
et al. [6] showed that combining a urethral smear with
lower urinary tract localization gave optimal results for
detecting urethral and prostatic inflammation. They
found that VB1 and VB2 examinations had low
sensitivity for detecting urethral inflammation. Examining both
the EPS and VB3 proved best for detecting prostatic fluid
inflammation. The current studies indicate that there are
clearly markers in urine which can aid in positively
identifying chronic prostates.
Current reports are limited in their definition of
adequate markers for the detection and follow-up of CP.
There is clearly a need for finding novel markers and it is
prudent to expedite current novel techniques to find them.
With the introduction of proteomics [7, 8] it would be
interesting to see what markers can be detected by the
proteomic evaluation of urine and seminal fluid in men
with CP.
References
1 Dai YP, Sun XZ, Zheng KL. Endotoxins in the prostatic
secretions of chronic prostatitis patients. Asian J Androl 2005;
7: 45-7.
2 Nickel JC, Alexander RB, Schaeffer AJ, Landis JR, Knauss JS,
Propert KJ; Chronic Prostatitis Collaborative Research
Network Study Group. Leukocytes and bacteria in men with
chronic prostatitis/chronic pelvic pain syndrome compared to
asymptomatic controls. J Urol 2003; 170: 818-22.
3 Li LJ, Shen ZJ, Lu YL, Fu SZ. The value of endotoxin
concentrations in expressed prostatic secretions for the diagnosis and
classification of chronic prostatitis. BJU Int 2001; 88: 536-9.
4 Ludwig M, Schroeder-Printzen I, Ludecke G, Weidner W.
Comparison of expressed prostatic secretions with urine after
prostatic massage: a means to diagnose chronic
prostatitis/inflammatory chronic pelvic pain syndrome. Urology 2000;
55: 175-7.
5 Ludwig M, Steltz C, Huwe P, Schaffer R, Altmannsberger M,
Weidner W. Immunocytological analysis of leukocyte
subpopulations in urine specimens before and after prostatic
massage. Eur Urol 2001; 39: 277-82.
6 Krieger JN, Jacobs R, Ross SO. Detecting urethral and
prostatic inflammation in patients with chronic prostatitis.
Urology 2000; 55: 186-92.
7 Kommu S, Sharifi R, Edwards S, Eeles R. Proteomics and
urine analysis: a potential promising new tool in urology. BJU
Int 2004; 93: 1172-3.
8 Kommu S, Sharifi R, Eeles RA. The proteomic approach to
urological biomarkers. BJU Int 2004; 94: 1215-6.
|